CVS HEALTH CORPORATION (CVS) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy bene...
CVS HEALTH CORPORATION (CVS) currently trades at a P/E ratio of 40.66 (historical range: 9.86–227.29, median: 20.17), placing it at the 61th percentile — above its historical average, P/S ratio of 0.29 (range: 0.15–0.34, 86th percentile — expensive relative to its history), EV/EBITDA of 36.44 (range: 12.62–61.09, 61th percentile).
Over the historical period (2024-08-30 to 2026-08-28), CVS HEALTH CORPORATION's P/E ratio has expanded by 720% over the observed period (from an average of 15.2 to 124.3).
CVS HEALTH CORPORATION appears slightly overvalued relative to its historical range, with most valuation metrics above their median levels.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 40.66 | 9.86 | 20.17 | 227.29 | 61th | above its historical average |
| P/S Ratio | 0.29 | 0.15 | 0.23 | 0.34 | 86th | expensive relative to its history |
| EV/EBITDA | 36.44 | 12.62 | 31.99 | 61.09 | 61th | above its historical average |
| FCF Yield | 0.03 | 0.02 | 0.06 | 0.11 | 13th | expensive relative to its history |